Avadel Pharmaceuticals Ownership | Who Owns Avadel Pharmaceuticals?
Avadel Pharmaceuticals Ownership Summary
Avadel Pharmaceuticals is owned by 79.72% institutional investors, 4.92% insiders, and 15.36% retail investors. Knoll capital management is the largest institutional shareholder, holding 0.65% of AVDL shares. Polar Capital Healthcare Opports Inc is the top mutual fund, with 3.74% of its assets in Avadel Pharmaceuticals shares.
AVDL Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Avadel Pharmaceuticals | 79.72% | 4.92% | 15.36% |
Sector | Healthcare Stocks | 76.79% | 9.87% | 13.34% |
Industry | Specialty & Generic Drug Manufacturers Stocks | 21.75% | 11.29% | 66.96% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Knoll capital management | 600.00K | 0.65% | $8.44M |
Schulhoff | 137.00K | 0.14% | $1.44M |
Geode capital management | - | - | - |
National bank of canada /fi/ | - | - | - |
Parallel advisors | - | - | - |
Advisorshares investments | - | - | - |
Nations financial group inc, /ia/ /adv | - | - | - |
Edge wealth management | - | - | - |
Gendell jeffrey l | - | - | - |
Zimmer partners, lp | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Knoll capital management | 600.00K | 5.68% | $8.44M |
Schulhoff | 137.00K | 0.53% | $1.44M |
Geode capital management | - | - | - |
National bank of canada /fi/ | - | - | - |
Parallel advisors | - | - | - |
Advisorshares investments | - | - | - |
Nations financial group inc, /ia/ /adv | - | - | - |
Edge wealth management | - | - | - |
Gendell jeffrey l | - | - | - |
Zimmer partners, lp | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Huntington national bank | 1.00 | - | - |
Knoll capital management | 600.00K | 5.68% | - |
Schulhoff | 137.00K | 0.53% | - |
Zurcher kantonalbank (zurich cantonalbank) | - | - | -19.00 |
Signaturefd | - | - | -22.00 |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Janus henderson group | - | - | -12.92M |
Rtw investments, lp | - | - | -8.80M |
Polar capital | - | - | -6.75M |
Gendell jeffrey l | - | - | -5.71M |
Braidwell lp | - | - | -4.11M |
Sold Out
Holder | Change |
---|---|
Zurcher kantonalbank (zurich cantonalbank) | -19.00 |
Signaturefd | -22.00 |
Cornerstone planning group | -85.00 |
Cva family office | -95.00 |
Cwm | -99.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 185 | 5.71% | 77,012,100 | -3.02% | 79 | 1.17% | 99 | 11.24% | 48 | 6.67% |
Dec 31, 2024 | 2 | -60.00% | 137,001 | -87.20% | - | 11.52% | - | - | - | -100.00% |
Sep 30, 2024 | 5 | -50.00% | 1,070,001 | -84.77% | 1 | 1.89% | - | -100.00% | 1 | - |
Jun 30, 2024 | 10 | -92.42% | 7,025,014 | -89.75% | 7 | 0.10% | 3 | -96.05% | 1 | -96.67% |
Mar 31, 2024 | 132 | 8.20% | 68,522,967 | 22.31% | 85 | 2.18% | 76 | 40.74% | 30 | 11.11% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Polar Capital Healthcare Opports Inc | 3.62M | 3.74% | - |
Vanguard US Total Market Shares ETF | 2.99M | 3.09% | - |
Vanguard Total Stock Mkt Idx Inv | 2.84M | 2.94% | - |
Janus Henderson Global Life Sciences | 2.54M | 2.64% | -131.86K |
Janus Henderson Global Life Sciences D | 2.48M | 2.57% | -9.18K |
iShares Russell 2000 ETF | 2.29M | 2.37% | 387.00 |
Janus Henderson Glb Life Scn I2 USD | 2.02M | 2.09% | -4.84K |
Janus Global Life Science AUSD | 2.02M | 2.09% | -16.05K |
Polar Capital Biotech S Inc | 1.50M | 1.56% | - |
Janus Henderson US Small Cap Growth | 1.48M | 1.54% | 313.10K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 21, 2025 | Palczuk Linda | - | Buy | $39.64K |
Jan 13, 2025 | Thornton Peter J. | - | Buy | $80.45K |
Jan 13, 2025 | Ende Eric J | - | Buy | $235.22K |
Dec 13, 2024 | MCHUGH THOMAS S | Chief Financial Officer | Buy | $24.02K |
Dec 11, 2024 | MCHUGH THOMAS S | Chief Financial Officer | Buy | $52.43K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | - |
2025 Q1 | 3 | - |
2024 Q4 | 7 | - |
2024 Q3 | - | - |
2024 Q2 | - | - |
AVDL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools